You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroesophageal Junction (Siewert I-III) Adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • toripalimab FOLFOX
  • (no location specified)
Aug 3, 2023

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +5 more
  • Biospecimen Collection
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Oct 11, 2023

Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

Not yet recruiting
  • Adenocarcinoma Esophagus
  • +3 more
  • (no location specified)
Sep 13, 2023

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • (no location specified)
Aug 18, 2022

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting
  • Advanced Esophageal Adenocarcinoma
  • +14 more
  • (no location specified)
Jan 3, 2023

Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

Recruiting
  • Adenocarcinoma of Stomach
  • Gentuximab Injection
  • Gentuximab Injection Placebo
  • Shanghai, Shanghai, China
    Shanghai Dongfang Hospital
Jun 16, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +10 more
  • Biopsy
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 20, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +23 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 5, 2022

Gastric Adenocarcinoma, Pancreas Adenocarcinoma, Gastric Tumor Trial (PT886)

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • (no location specified)
Aug 10, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
May 12, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • CS1001 monoclonal antibody
  • +3 more
  • Beijing, China
    Beijing Cancer Hospital
Sep 27, 2022

Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8

Recruiting
  • Advanced Gastric Adenocarcinoma
  • +32 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 2, 2022

Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +42 more
  • Duarte, California
  • +9 more
Jan 21, 2023

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +30 more
  • Scottsdale, Arizona
  • +11 more
Apr 4, 2022

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8

Not yet recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 15, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Trifluridine and Tipiracil Hydrochloride
  • Talazoparib Tosylate
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 2, 2022

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

Not yet recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +9 more
  • Atezolizumab
  • +12 more
  • (no location specified)
Apr 26, 2023

Gastric Cancer Trial (Sintilimab)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Oct 21, 2022

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I

Recruiting
  • Clinical Stage 0 Gastric Cancer AJCC v8
  • +27 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +18 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Gastric Cancer Trial in China (IN10018, Docetaxel)

Completed
  • Gastric Cancer
  • Anyang, Henan, China
  • +7 more
Nov 15, 2022

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +66 more
  • Phoenix, Arizona
  • +76 more
Jan 11, 2023

Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in La Jolla, Washington, Hackensack (CYNK-101, Pembrolizumab,

Recruiting
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer
  • CYNK-101
  • +6 more
  • La Jolla, California
  • +2 more
Jul 12, 2022

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +33 more
  • Communication Intervention
  • +2 more
  • New York, New York
  • +3 more
Jun 29, 2022